Yvette Drew

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Endometrial Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Amy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, J Maxwell Douglas, Sameer Shankar, Branden J Lynch, Samuel C Y Leung, Spencer D Martin, Janine Senz, Amy Lum, Yvette Drew, C Blake Gilks, David G Huntsman, Jessica Nell McAlpine
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Amy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, J Maxwell Douglas, Sameer Shankar, Branden J Lynch, Samuel C Y Leung, Spencer D Martin, Janine Senz, Amy Lum, Yvette Drew, C Blake Gilks, David G Huntsman, Jessica Nell McAlpine
Targeted and shallow whole genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Amy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, J Maxwell Douglas, Sameer Shankar, Branden J Lynch, Samuel C Y Leung, Spencer D Martin, Janine Senz, Amy Lum, Yvette Drew, C Blake Gilks, David G Huntsman, Jessica Nell McAlpine
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Amy Jamieson, Juliana Sobral de Barros, Dawn R Cochrane, J Maxwell Douglas, Sameer Shankar, Branden J Lynch, Samuel C Y Leung, Spencer D Martin, Janine Senz, Amy Lum, Yvette Drew, C Blake Gilks, David G Huntsman, Jessica Nell McAlpine
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Yvette Drew, Jae-Weon Kim, Richard T Penson, David M O'Malley, Christine Parkinson, Patricia Roxburgh, Ruth Plummer, Seock-Ah Im, Martina Imbimbo, Michelle Ferguson, Ora Rosengarten, Neeltje Steeghs, Min Hwan Kim, Einav Nili Gal-Yam, Daliah Tsoref, Jae-Hoon Kim, Benoit You, Maja J A de Jonge, Roy I Lalisang, Eelke H Gort, Sara Bastian, Kassondra Meyer, Laura Feeney, Nigel Baker, Mei-Lin Ah-See, Susan M Domchek, Susana Banerjee
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alice Bradbury, Frank T Zenke, Nicola J Curtin, Yvette Drew
The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response. Cells 11 (15) (2022)
Hannah L Smith, Elaine Willmore, Asima Mukhopadhyay, Yvette Drew, Nicola J Curtin
Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling. Cancers 14 (22) (2022)
Nikolay Grechko, Viera Skarbova, Monika Tomaszewska-Kiecana, Rodryg Ramlau, Piotr Centkowski, Yvette Drew, Rafal Dziadziuszko, Milada Zemanova, Jeri Beltman, Eileen Nash, Jenn Habeck, Mingxiang Liao, Jim J Xiao
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment. Cancer chemotherapy and pharmacology 88 (2) (2021)
Nicola J Curtin, Yvette Drew, Sweta Sharma-Saha
Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy. Nature reviews. Clinical oncology 16 (12) (2020)
Timothy Anthony Yap, David Shao Peng Tan, Angelika Terbuch, Reece Caldwell, Christina Guo, Boon Cher Goh, Heong Valerie Yue Ming, Noor R Md Haris, Saira Bashir, Yvette Drew, David S Hong, Funda Meric-Bernstam, Gary Wilkinson, Joseph Hreiki, Antje M Wengner, Friedhelm Bladt, Andreas Schlicker, Matthias Ludwig, Yinghui Zhou, Li Liu, Sonal Bordia, Ruth Plummer, Eleni Lagkadinou, Johann S de Bono
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors. Cancer discovery 11 (1) (2020)
Timothy Anthony Yap, Rebecca S Kristeleit, Vasiliki Michalarea, Stephen J Pettitt, Joline S J Lim, Suzanne Carreira, Desamparados Roda, Rowan Miller, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Daniel Nava Rodrigues, Sarah Ward, Ruth Matthews, Mona Parmar, Alison Turner, Nina Tunariu, Neha Chopra, Heidrun Gevensleben, Nicholas C Turner, Ruth Ruddle, Florence I Raynaud, Shaun Decordova, Karen E Swales, Laura Finneran, Emma C Hall, Paul Rugman, Justin P O Lindemann, Andrew Foxley, Christopher J Lord, Udai Banerji, Ruth Plummer, Bristi Basu, Juanita S Lopez, Yvette Drew, Johann S de Bono
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers. Cancer discovery 10 (10) (2020)
David S Hong, Nicole Concin, Ignace Vergote, Johann S de Bono, Brian M Slomovitz, Yvette Drew, Hendrik-Tobias Arkenau, Jean-Pascal Machiels, James F Spicer, Robert Jones, Martin D Forster, Nathalie Cornez, Christine Gennigens, Melissa L Johnson, Fiona C Thistlethwaite, Reshma A Rangwala, Srinivas Ghatta, Kristian Windfeld, Jeffrey R Harris, Ulrik Niels Lassen, Robert L Coleman
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)
Yvette Drew, Rebecca S Kristeleit, Ana Oaknin, Isabelle Ray-Coquard, Noor Md Haris, Elizabeth M Swisher
Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10. The oncologist 25 (1) (2019)
Lucy Gentles, Bojidar Goranov, Elizabeth Matheson, Ashleigh Herriott, Angelika Kaufmann, Sally Hall, Asima Mukhopadhyay, Yvette Drew, Nicola J Curtin, Rachel L O'Donnell
Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types. Cancers 11 (3) (2019)